Concepedia

Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy

Paul L. Baron, Peter D. Beitsch, Danielle Boselli, James T. Symanowski, James Pellicane, J. David Beatty, Paul Richards, Angela Mislowsky, Charles H. Nash, Laura A. Lee,

Annals of Surgical Oncology · 2015 · 31 citations · 7 references

DOIFull text

Open access

References

7

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer et al. · Journal of Clinical Oncology · 2012 · 2.6K citations

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Henry M. Kuerer, Lisa A. Newman, Terry L. Smith et al. · Journal of Clinical Oncology · 1999 · 1.3K citations

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

Laura J. Esserman, Donald A. Berry, Angela DeMichele et al. · Journal of Clinical Oncology · 2012 · 435 citations · Full text

A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response

Oscar Krijgsman, Paul Roepman, Wilbert Zwart et al. · Breast Cancer Research and Treatment · 2011 · 148 citations

, , +10

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

Pat W. Whitworth, Lisette Stork‐Sloots, Femke A. de Snoo et al. · Annals of Surgical Oncology · 2014 · 88 citations · Full text